Shifting the Focus From Cost to Value: Key Stakeholder Perspectives
| Autor: | Babette S. Edgar, Pamela A. Hymel, Schumarry H. Chao, Michael B. Nichol, Dexter W. Shurney |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Government
Prescription drug business.industry Health Policy media_common.quotation_subject Stakeholder Pharmaceutical Science Pharmacy Public relations Health care Medication therapy management Medicine Medicare Part D Quality (business) business Medicaid health care economics and organizations media_common |
| Zdroj: | Journal of Managed Care Pharmacy. 12:1-26 |
| ISSN: | 1944-706X 1083-4087 |
| DOI: | 10.18553/jmcp.2006.12.s6-b.1 |
| Popis: | OBJECTIVE: To examine the federal government's current health care initiatives in the Centers for Medicare and Medicaid Services (CMS) to improve quality of care and cost-effectiveness around the prescription drug benefit. SUMMARY: The government has a unique perspective on quality and outcome. Pharmacists need a working knowledge of 3 areas: (1) Medicare Part D, (2) medication therapy management efforts, and (3) demonstration projects. All of these will make demands on health care providers but should result in better outcomes data and patient care. All of these areas also have value components, and all have strategic implications as 2006 moves into 2007. CONCLUSION: CMS does not consider managing cost and providing value to be mutually exclusive and is attempting to move America's health care toward a value based program. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|